GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellCura ASA (FRA:C6L) » Definitions » Scaled Net Operating Assets

CellCura ASA (FRA:C6L) Scaled Net Operating Assets : 0.20 (As of Jun. 2014)


View and export this data going back to . Start your Free Trial

What is CellCura ASA Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

CellCura ASA's operating assets for the quarter that ended in Jun. 2014 was €1.89 Mil. CellCura ASA's operating liabilities for the quarter that ended in Jun. 2014 was €1.43 Mil. CellCura ASA's Total Assets for the quarter that ended in Mar. 2014 was €2.31 Mil. Therefore, CellCura ASA's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2014 was 0.20.


CellCura ASA Scaled Net Operating Assets Historical Data

The historical data trend for CellCura ASA's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellCura ASA Scaled Net Operating Assets Chart

CellCura ASA Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Scaled Net Operating Assets
Get a 7-Day Free Trial 1.04 1.72 0.47 0.19 0.26

CellCura ASA Quarterly Data
Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.28 0.38 0.24 0.35 0.20

Competitive Comparison of CellCura ASA's Scaled Net Operating Assets

For the Biotechnology subindustry, CellCura ASA's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CellCura ASA's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CellCura ASA's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where CellCura ASA's Scaled Net Operating Assets falls into.



CellCura ASA Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

CellCura ASA's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2013 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2013 )
=(Operating Assets (A: Dec. 2013 )-Operating Liabilities (A: Dec. 2013 ))/Total Assets (A: Dec. 2012 )
=(2.365-1.279)/4.14
=0.26

where

Operating Assets(A: Dec. 2013 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=2.392 - 0.027
=2.365

Operating Liabilities(A: Dec. 2013 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=3.571 - 1.189 - 1.103
=1.279

CellCura ASA's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2014 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Jun. 2014 )
=(Operating Assets (Q: Jun. 2014 )-Operating Liabilities (Q: Jun. 2014 ))/Total Assets (Q: Mar. 2014 )
=(1.891-1.427)/2.308
=0.20

where

Operating Assets(Q: Jun. 2014 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=1.905 - 0.014
=1.891

Operating Liabilities(Q: Jun. 2014 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=4.11 - 1.036 - 1.647
=1.427

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CellCura ASA Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of CellCura ASA's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


CellCura ASA (FRA:C6L) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Unionsgata 18, Skien, NOR, 3732
CellCura ASA is engaged in the development of novel equipment & products for use in Assisted Reproductive Technology & Stem Cell Research globally. The company also offers software solutions used in ART lab for securing the storage & management of data.

CellCura ASA (FRA:C6L) Headlines

No Headlines